Floratech has appointed Chad Dubbelde to the newly-created position of market development analyst. Prior to his appointment, he served as a research associate at two San Diego biotechnology firms.
Before that, Chad Dubbelde worked at the Howard Hughes Medical Institute where he established high-throughput DNA sequencing and molecular screening methods in support of research that identified new genes that regulate the molecular mechanism of the natural killer cell. In addition, he has contributed as a member of the DNA sequencing team responsible, in part, for the Human Genome Project at the Washington University School of Medicine’s Genome Sequencing Center.
Chad Dubbelde has a BA in biology and an MBA.
